The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction

• Status: Recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

This pilot project is a randomized controlled trial where induced patients receive an intervention of oxytocin discontinuation once in the active stage of labor (≥6 cm dilation). The intent is to reduce uterine hyperstimulation and fetal distress, therefore, lowering cesarean sections (CS) in first time mothers at term (≥ 37 weeks), with a cephalic presenting singleton fetus, without increasing maternal or neonatal morbidity. If REDUCE-I pilot trial suggests a safe reduction in CS rates and patient satisfaction, application for a multi-centre randomized controlled trial would follow.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Calgary
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• pregnant women undergoing induction of labor with oxytocin.

• Primiparous

• 18 years old or older

• at term (≥37 weeks)

• cephalic presenting

• singleton fetus

Exclusion Criteria:

• Multiple pregnancies

• known fetal congenital or chromosomal anomalies